Skip to main content
. Author manuscript; available in PMC: 2022 Jun 12.
Published in final edited form as: JACC Clin Electrophysiol. 2020 Nov 25;7(3):380–390. doi: 10.1016/j.jacep.2020.08.028

Figure 1.

Figure 1.

Enrollment and distribution of PVC-Cardiomyopathy in CHF-STAT study. (A) Enrollment of CHF-STAT study and rationale for final 421 patients included in secondary analysis. (B) Prevalence of PVC-Cardiomyopathy (PVC-CM) by treatment randomization including PVC suppression and improvement in LVEF.